The prognostic impact of squamous differentiation in bladder cancer after radical cystectomy: a propensity score-matched comparative analysis of pure urothelial carcinoma, urothelial carcinoma with squamous differentiation, and squamous cell carcinoma - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Prognostic Significance of Squamous Differentiation in Bladder Cancer Following Radical Cystectomy: A Comparative Analysis of Pure Urothelial Carcinoma, Urothelial Carcinoma with Squamous Differentiation, and Squamous Cell Carcinoma Using Propensity Score Matching

  • By

  • Miaolin Guo

  • Yu Zhou

  • Xinjie Lin

  • Zhihong Xu

  • Yuxuan You

  • July 7, 2026

Share

  • 1

    The study evaluated the prognostic impact of squamous differentiation in bladder cancer after radical cystectomy.

  • 2

    Patients were categorized into three groups: pure urothelial carcinoma, urothelial carcinoma with squamous differentiation, and pure squamous cell carcinoma.

  • 3

    Unadjusted analysis showed that patients with squamous differentiation had worse overall survival compared to those with pure urothelial carcinoma.

  • 4

    After propensity score matching, squamous differentiation remained an independent risk factor for worse overall survival.

  • 5

    The findings suggest that squamous differentiation is associated with more aggressive tumor biology in bladder cancer.

Original Source(s)

The prognostic impact of squamous differentiation in bladder cancer after radical cystectomy: a propensity score-matched comparative analysis of pure urothelial carcinoma, urothelial carcinoma with squamous differentiation, and squamous cell carcinoma

  • by Miaolin Guo, Yu Zhou, Xinjie Lin, Zhihong Xu, Yuxuan You

  • July 7, 2026

Related Content

ORC6 marks a replication-active malignant epithelial state and is associated with immune-low features in oral squamous cell carcinoma

Ferroptosis contributes to quercetin-induced anti-cancer activity through blockade of LGR4/NF-κB/GPX4 axis in oral squamous cell carcinoma

Global Skin Cancer Burden From 1990 to 2023 and Projection to 2050